Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Denmark
/
Healthcare
Create a narrative
Embla Medical hf Community
CPSE:EMBLA Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Embla Medical hf
Popular
Undervalued
Overvalued
Community Investing Ideas
EMBL
Embla Medical hf
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
New Product Launches And Manufacturing Improvements Will Shape Future Reach
Key Takeaways New product launches, Medicare expansion, and international growth initiatives are expected to drive sales and boost revenue. Cost reduction efforts, manufacturing efficiency, and share buyback program could enhance profitability and EPS growth.
View narrative
DKK 33.15
FV
2.9% undervalued
intrinsic discount
8.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
EMBLA
EMBLA
Embla Medical hf
Your Fair Value
DKK
Current Price
DKK 32.20
12.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.3b
Earnings US$106.8m
Advanced
Set Fair Value